Translational Science and Therapeutics Division, Fred Hutch
Aven Foundation Endowed Chair
Dr. Amanda Paulovich is a leader in proteomics, the study of proteins — the cell’s workhorse molecules. Due to a lack of tools, proteomics has lagged behind the study of genes, which provide the blueprints for proteins. And just as a blueprint can’t tell you everything about a finished house, our genetic blueprint only reveals part of the biological picture. By developing powerful protein-measuring tools, Dr. Paulovich helps to fill in this picture and open the door to treatments tailored to individual cancer patients.
Her team has spearheaded the development of assays that use a technique called multiple reaction monitoring mass spectrometry, or MRM-MS, to detect and precisely measure the amount of a particular protein. This technology will help researchers combine detailed information about proteins with genetic data to learn, for instance, which genetic mutations drive a cancer’s development and suggest new therapeutic targets.
Director, Clinical Research Proteomics Platform
Brotman Baty Institute for Precision Medicine
Professor, Department of Medicine, Division of Hematology and Oncology
University of Washington School of Medicine
Associate Faculty Member, Molecular and Cellular Biology Program
University of Washington
Fellowship, Medical Oncology, Dana Farber Cancer Institute, 2004
Postdoctoral Fellowship, Computational Biology, MIT-Whitehead Center for Genomic Research, 2003
Residency, Internal Medicine, Massachusetts General Hospital, 2000
MD, University of Washington, 1998
PhD, Genetics, University of Washington, 1996
BS, Biological Sciences, Carnegie Mellon University, 1988
— Dr. Amanda Paulovich
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210